I3LUNG at ESMO 2024

I3LUNG was featured at the ESMO – European Society for Medical Oncology, held from September 13 to 17 in Barcelona.

The poster titled: “Digital pathology predicts PD-L1 expression in metastatic NSCLC patients treated with immunotherapy” was presented by our PI, Dr. ArselaPrelaj, on September 14th at 11 AM. Additionally, the poster was available for viewing throughout the day, from 9 AM to 5 AM.

Take a look to the I3LUNG poster:

We invite you to watch the video shares more details about our project.

Stay tuned for more information and don’t forget to follow us on our social networks:

LinkedIn | Twitter | Instagram | Facebook

Share on: